How do you find using the New Zealand Gazette? Please give your feedback by completing this survey.

Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Povidine iodine 10 mg/mL equivalent to 1 mg/mL available iodine in 120 ml Solution, oral topical Faulding Pharmaceuticals, Salisbury, South Australia, Australia Betadine Ready to Use Sore Throat Gargle Doxazosin mesylate equivalent to 1 mg, 2 mg, 4 mg, 8 mg doxazosin Tablet Douglas Pharmaceuticals Limited, Mount Roskill, Auckland Cardoxan Lamotrigine 25 mg, 50 mg, 100 mg, 200 mg Tablets Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom Lamictal Mivacurium chloride equivalent to 2 mg/mL mivacurium in 5 mL, 10 mL Injection (ampoules) Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom Mivacron Trandolapril 0.5 mg, 1 mg, 2 mg Capsules Roussel-Uclaf Usiphar Production Unit, Compeigne, France Odrik Dextromethorphan hydrobromide 15 mg, paracetamol 325 mg, pseudoephedrine hydrochloride 30 mg Caplet Sigma Pharmaceuticals Pty Limited, Croydon, Victoria, Australia Orthoxicol Cold and Flu Paracetamol 325 mg, pseudoephedrine hydrochloride 30 mg Caplet Sigma Pharmaceuticals Pty Limited, Croydon, Victoria, Australia Orthoxicol Headcold Paracetamol 120 mg/5 mL in 2 L, 250 mg/5 mL in 2 L Liquid Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Paracetamol Liquid Milrinone lactate equivalent to 1 mg/mL milrinone in 10 mL Injection (ampoule) Sanofi Winthrop Inc., McPherson, Kansas, United States of Amercia Primacor Interferon alpha-2a 3, 4.5, 6, 9 million IU/ml in 1 mL, 18 million IU/3 mL in 3 mL Solution for injection (vial) F Hoffmann-La Roche Limited, Basle, Switzerland Roferon-A Aprotinin 100 000 kiu/10 mL in 50 mL, 100 mL, 200 mL Injection (vials) Bayer AG, Leverkusen, Germany Trasylol Dated this 5th day of March 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection pursuant to delegation given by the Minister of Health on 18 January 1996.
Publication Date
7 Mar 1996

Notice Number

1996-go1611

Page Number

725